Effect of combined treatment with rosiglitazone and body weight control on the patients with impaired glucose tolerance
- VernacularTitle:罗格列酮联合减低体重对糖耐量受损患者的影响
- Author:
Jianchao GUO
;
Zhengzheng BI
;
Honggang ZHAO
;
Zuncheng ZHANG
;
Shaoxiong ZHENG
;
Xiaodong LI
- Publication Type:Journal Article
- Keywords:
Impaired glucose tolerance;
Insulin resistance;
Rosiglitazone;
Body weight
- From:
Chinese Journal of Endocrinology and Metabolism
2008;24(2):143-144
- CountryChina
- Language:Chinese
-
Abstract:
After treatment for 3 months in the patients with impaired glucose tolerance (IGT), plasma glucose, insulin and homeostasis model assessment for insulin resistance (HOMA-IR) were decreased both in rosiglitazone therapy group and in the group treated with rosiglitazone combined with body weight control.Those parameters in the latter group were decreased more significantly than those in the former.Rosiglitazone ameliorates the insulin resistance in patients with IGT, which is further improved when combined with body weight control.
